The invention relates to a pharmaceutical composition comprising a synergic combination of an anticonvulsant agent such as the active principle: gabapentin and a non-steroidal anti-inflammatory agent such as the active principle: meloxicam, which are formulated in a single dosage unit for oral administration, said composition being intended for the treatment of neuropathic pain caused by different etiologies.